Alto Neuroscience Inc. ANRO
$20.75
▲ +0.19% 24H
About
Alto Neuroscience Inc. is a biotechnology company that focuses on developing precision therapeutics for psychiatric disorders. The company's primary objective is to utilize advanced neurobiological insights and digital tools to tailor treatments for conditions like depression, anxiety, and other mental health disorders…
SectorHealthcare
ExchangeNYSE
IndustryBiotechnology
CountryUnited States
Employees68
TickerANRO
Statistics
Market Cap$727.3M
Revenue (TTM)$0
Net Income-$63.2M
Net Margin—
EPS$-2.19
P/E-9.82
P/S—
P/B2.83
EV/EBITDA-5.82
ROE-38.9%
Dividend Yield—
Price$20.75
Data: Twelve Data · Revenue = mcap / P/S